Building a pharmacological lexicon: small molecule discovery in academia - PubMed (original) (raw)
Review
Building a pharmacological lexicon: small molecule discovery in academia
John S Lazo et al. Mol Pharmacol. 2007 Jul.
Abstract
Small molecules are powerful pharmacological tools to dissect biological events. There is now considerable interest in expanding efforts to identify and use small molecules targeting proteins encoded in the genomes of humans and pathogenic organisms. Integration of the principles of molecular pharmacology with contemporary high-throughput and high-content screening technologies is essential for the success of these discovery activities. We present some of the challenges and opportunities provided by the Molecular Library Screening Centers Network (MLSCN), which is a National Institutes of Health Roadmap Initiative.
Similar articles
- Hit finding: towards 'smarter' approaches.
Langer T, Hoffmann R, Bryant S, Lesur B. Langer T, et al. Curr Opin Pharmacol. 2009 Oct;9(5):589-93. doi: 10.1016/j.coph.2009.06.001. Epub 2009 Jul 1. Curr Opin Pharmacol. 2009. PMID: 19576852 Review. - Novel trends in high-throughput screening.
Mayr LM, Bojanic D. Mayr LM, et al. Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Curr Opin Pharmacol. 2009. PMID: 19775937 Review. - Fluorophore-tagged GPCR ligands.
Middleton RJ, Kellam B. Middleton RJ, et al. Curr Opin Chem Biol. 2005 Oct;9(5):517-25. doi: 10.1016/j.cbpa.2005.08.016. Curr Opin Chem Biol. 2005. PMID: 16125436 Review. - Data mining a small molecule drug screening representative subset from NIH PubChem.
Xie XQ, Chen JZ. Xie XQ, et al. J Chem Inf Model. 2008 Mar;48(3):465-75. doi: 10.1021/ci700193u. Epub 2008 Feb 27. J Chem Inf Model. 2008. PMID: 18302356 - Stem cells as screening tools in drug discovery.
McNeish JD. McNeish JD. Curr Opin Pharmacol. 2007 Oct;7(5):515-20. doi: 10.1016/j.coph.2007.06.005. Epub 2007 Aug 6. Curr Opin Pharmacol. 2007. PMID: 17681491 Review.
Cited by
- Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.
Brothers SP, Saldanha SA, Spicer TP, Cameron M, Mercer BA, Chase P, McDonald P, Wahlestedt C, Hodder PS. Brothers SP, et al. Mol Pharmacol. 2010 Jan;77(1):46-57. doi: 10.1124/mol.109.058677. Epub 2009 Oct 16. Mol Pharmacol. 2010. PMID: 19837904 Free PMC article. - Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening.
Madoux F, Li X, Chase P, Zastrow G, Cameron MD, Conkright JJ, Griffin PR, Thacher S, Hodder P. Madoux F, et al. Mol Pharmacol. 2008 Jun;73(6):1776-84. doi: 10.1124/mol.108.045963. Epub 2008 Mar 11. Mol Pharmacol. 2008. PMID: 18334597 Free PMC article. - An overview of the PubChem BioAssay resource.
Wang Y, Bolton E, Dracheva S, Karapetyan K, Shoemaker BA, Suzek TO, Wang J, Xiao J, Zhang J, Bryant SH. Wang Y, et al. Nucleic Acids Res. 2010 Jan;38(Database issue):D255-66. doi: 10.1093/nar/gkp965. Epub 2009 Nov 19. Nucleic Acids Res. 2010. PMID: 19933261 Free PMC article. - Fluorescent RNA Aptamers as a Tool to Study RNA-Modifying Enzymes.
Svensen N, Jaffrey SR. Svensen N, et al. Cell Chem Biol. 2016 Mar 17;23(3):415-25. doi: 10.1016/j.chembiol.2015.11.018. Epub 2016 Feb 11. Cell Chem Biol. 2016. PMID: 26877022 Free PMC article. - Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.
Soares KM, Blackmon N, Shun TY, Shinde SN, Takyi HK, Wipf P, Lazo JS, Johnston PA. Soares KM, et al. Assay Drug Dev Technol. 2010 Apr;8(2):152-74. doi: 10.1089/adt.2009.0247. Assay Drug Dev Technol. 2010. PMID: 20070233 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources